# Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

> **NCT01074931** · — · COMPLETED · sponsor: **Abbott** · enrollment: 98 (actual)

## Conditions studied

- HIV-1 Infections

## Interventions

- **DRUG:** Lopinavir/ritonavir (Kaletra)

## Key facts

- **NCT ID:** NCT01074931
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2011-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01074931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01074931, "Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01074931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*